FDA Urges Providers To Work With Registered Compounders

Law360, New York (December 02, 2013, 3:39 PM ET) -- U.S. public health regulators have expanded oversight of drug compounders choosing to register with the U.S. Food and Drug Administration, but the agency will help boost participation despite its voluntary nature by urging hospitals and doctors to work with FDA-registered facilities, FDA officials said Monday.

FDA Commissioner Margaret Hamburg stressed that although it is only voluntary for compounders producing so-called high-risk drugs —  which FDA officials said Monday include sterile medications that are injected into patients — to register with the FDA, the agency will work...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers